Entheon Biomedical Valuation
| ENTBF Stock | USD 0.17 0.06 26.09% |
Entheon Biomedical seems to be undervalued based on Macroaxis valuation methodology. Our model computes the value of Entheon Biomedical Corp from reviewing the firm fundamentals such as Shares Owned By Insiders of 8.63 %, operating margin of (60.27) %, and Shares Outstanding of 59.09 M as well as analyzing its technical indicators and probability of bankruptcy. . In general, most investors advise locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.
Undervalued
Today
Please note that Entheon Biomedical's price fluctuation is out of control at this time. Calculation of the real value of Entheon Biomedical Corp is based on 3 months time horizon. Increasing Entheon Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Entheon otc stock is determined by what a typical buyer is willing to pay for full or partial control of Entheon Biomedical Corp. Since Entheon Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Entheon OTC Stock. However, Entheon Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.17 | Real 0.18 | Hype 0.17 |
The real value of Entheon OTC Stock, also known as its intrinsic value, is the underlying worth of Entheon Biomedical Corp OTC Stock, which is reflected in its stock price. It is based on Entheon Biomedical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Entheon Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Entheon Biomedical Corp helps investors to forecast how Entheon otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Entheon Biomedical more accurately as focusing exclusively on Entheon Biomedical's fundamentals will not take into account other important factors: Entheon Biomedical Total Value Analysis
Entheon Biomedical Corp is currently forecasted to have takeover price of 1.12 M with market capitalization of 1.3 M, debt of 300 K, and cash on hands of 467.58 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Entheon Biomedical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.12 M | 1.3 M | 300 K | 467.58 K |
Entheon Biomedical Investor Information
The company has price-to-book (P/B) ratio of 0.22. Some equities with similar Price to Book (P/B) outperform the market in the long run. Entheon Biomedical Corp recorded a loss per share of 0.11. The entity last dividend was issued on the 12th of November 2020. Entheon Biomedical Corp is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Entheon Biomedical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Entheon Biomedical has an asset utilization ratio of 0.22 percent. This implies that the OTC Stock is making $0.002172 for each dollar of assets. An increasing asset utilization means that Entheon Biomedical Corp is more efficient with each dollar of assets it utilizes for everyday operations.Entheon Biomedical Ownership Allocation
Entheon Biomedical holds a total of 59.09 Million outstanding shares. Entheon Biomedical Corp shows 8.63 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Entheon Biomedical Profitability Analysis
The company reported the revenue of 21.67 K. Net Loss for the year was (8.89 M) with profit before overhead, payroll, taxes, and interest of 9.13 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Entheon Biomedical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Entheon Biomedical and how it compares across the competition.
About Entheon Biomedical Valuation
The otc valuation mechanism determines Entheon Biomedical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Entheon Biomedical. We calculate exposure to Entheon Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Entheon Biomedical's related companies.Entheon Biomedical Corp. operates as a biotechnology research and drug development company. Entheon Biomedical Corp. is headquartered in Vancouver, Canada. ENTHEON BIOMEDICAL operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
8 Steps to conduct Entheon Biomedical's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Entheon Biomedical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Entheon Biomedical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Entheon Biomedical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Entheon Biomedical's revenue streams: Identify Entheon Biomedical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Entheon Biomedical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Entheon Biomedical's growth potential: Evaluate Entheon Biomedical's management, business model, and growth potential.
- Determine Entheon Biomedical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Entheon Biomedical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Entheon Biomedical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Entheon Biomedical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 59.1 M | |
| Retained Earnings | -13.5 M |
Complementary Tools for Entheon OTC Stock analysis
When running Entheon Biomedical's price analysis, check to measure Entheon Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entheon Biomedical is operating at the current time. Most of Entheon Biomedical's value examination focuses on studying past and present price action to predict the probability of Entheon Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entheon Biomedical's price. Additionally, you may evaluate how the addition of Entheon Biomedical to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |